Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2

Joseph A. Bell, Elizabeth R. Davies, Christopher J. Brereton, Milica Vukmirovic, James J.W. Roberts, Kerry Lunn, Leanne Wickens, Franco Conforti, Robert A. Ridley, Jessica Ceccato, Lucy N. Sayer, David A. Johnston, Andres F. Vallejo, Aiman Alzetani, Sanjay Jogai, Ben G. Marshall, Aurelie Fabre, Luca Richeldi, Phillip D. Monk, Paul Skipp, Naftali Kaminski, Emily Offer, Yihua Wang, Donna E. Davies, Mark G. Jones

Open source

DOI
10.1016/j.xcrm.2024.101695
Published
2024-09
Container
Cell Reports Medicine
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.xcrm.2024.101695,
  title = {Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2},
  author = {Joseph A. Bell and Elizabeth R. Davies and Christopher J. Brereton and Milica Vukmirovic and James J.W. Roberts and Kerry Lunn and Leanne Wickens and Franco Conforti and Robert A. Ridley and Jessica Ceccato and Lucy N. Sayer and David A. Johnston and Andres F. Vallejo and Aiman Alzetani and Sanjay Jogai and Ben G. Marshall and Aurelie Fabre and Luca Richeldi and Phillip D. Monk and Paul Skipp and Naftali Kaminski and Emily Offer and Yihua Wang and Donna E. Davies and Mark G. Jones},
  year = {2024},
  journal = {Cell Reports Medicine},
  doi = {10.1016/j.xcrm.2024.101695},
  url = {https://doi.org/10.1016/j.xcrm.2024.101695}
}

RIS

TY  - JOUR
TI  - Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2
AU  - Joseph A. Bell
AU  - Elizabeth R. Davies
AU  - Christopher J. Brereton
AU  - Milica Vukmirovic
AU  - James J.W. Roberts
AU  - Kerry Lunn
AU  - Leanne Wickens
AU  - Franco Conforti
AU  - Robert A. Ridley
AU  - Jessica Ceccato
AU  - Lucy N. Sayer
AU  - David A. Johnston
AU  - Andres F. Vallejo
AU  - Aiman Alzetani
AU  - Sanjay Jogai
AU  - Ben G. Marshall
AU  - Aurelie Fabre
AU  - Luca Richeldi
AU  - Phillip D. Monk
AU  - Paul Skipp
AU  - Naftali Kaminski
AU  - Emily Offer
AU  - Yihua Wang
AU  - Donna E. Davies
AU  - Mark G. Jones
PY  - 2024
JO  - Cell Reports Medicine
DO  - 10.1016/j.xcrm.2024.101695
UR  - https://doi.org/10.1016/j.xcrm.2024.101695
ER  - 

APA

Bell, J. A., Davies, E. R., Brereton, C. J., Vukmirovic, M., Roberts, J. J., Lunn, K., Wickens, L., Conforti, F., Ridley, R. A., Ceccato, J., Sayer, L. N., Johnston, D. A., Vallejo, A. F., Alzetani, A., Jogai, S., Marshall, B. G., Fabre, A., Richeldi, L., Monk, P. D., Skipp, P., Kaminski, N., Offer, E., Wang, Y., Davies, D. E., & Jones, M. G. (2024). Spatial transcriptomic validation of a biomimetic model of fibrosis enables re-evaluation of a therapeutic antibody targeting LOXL2. Cell Reports Medicine. https://doi.org/10.1016/j.xcrm.2024.101695

Source records